Cracking Cancer's Mysteries

The first part of 2022 is giving us a glimpse of humanity’s future relationship with COVID-19.

Reviving the Cancer Moonshot, disentangling the microbiome's effect in cancer, the observer effect, and more

Detailed analyses of cohesin’s movements indicate how this protein complex hauls chromatin fibers to package DNA into loops.

Coupling a diet low in calories, sugar, and protein with existing cancer drugs treats triple-negative breast cancer in mice, and low blood glucose is associated with better cancer outcomes in human patients.

An epigenome-wide association study found more than a dozen methylation changes in placental DNA that correlated with expectant mothers’ self-reports of depression and stress during their pregnancy.

Researchers link a stretch of DNA to a peptide of interest and measure current changes as the molecule is pulled by a helicase through a nanopore.

The biotech industry is chipping away at the obstacles standing between the lab and the dinner plate.

A new wave of research is recruiting patients and other members of the public to serve as equal partners, bringing fresh perspectives to research on diseases and other conditions.

Before its association with a pining for the toys or TV shows of yesteryear, nostalgia was deemed a dangerous psychiatric disorder.

When micronuclei rupture, chromosomes break, recombine, and form circles, causing inflammation and promoting carcinogenic growth.

From diagnosis to tracking treatment responses, bacteria and other microbes in the blood, gut, and tumors of cancer patients may provide helpful hints for improving their care.

The movements of so-called jumping genes can generate the genetic diversity needed to drive evolutionary change in populations over time.  

The hinge region of cohesin pulls DNA to two head regions, like a person’s hand-to-hand motion of pulling on a rope.

Adapting DNA nanopore sequencing to peptides allows researchers to identify single amino acid differences.